Improving safety and drug development for infectious diseases and bioterrorism
Official title: Enhancement of Resilience of the UTHSC RBL Facility, Biosafety and Countermeasure Discovery
Funded at University of Tennessee Health Sci Ctr · NIH-10910179 · Data updated 2026-11-12
This study is all about making a special lab at the University of Tennessee better at creating new medicines, vaccines, and tests to help keep everyone safe from new diseases and threats, and it’s designed for anyone interested in how we can be better prepared for health emergencies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | August 18, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $2,385,204 |
| NIH project number | 5UC7AI180313-02 |
| Project ID | NIH-10910179 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk for emerging infectious diseases or those involved in biodefense efforts.
✕Less likely to help
Patients with stable, non-infectious conditions may not receive direct benefits from this research.
What this research studies
This research focuses on enhancing the capabilities of the University of Tennessee Health Science Center's Regional Biocontainment Laboratory to develop new drugs, vaccines, and diagnostics aimed at protecting the public from emerging infectious diseases and bioterrorism threats. The project will create specialized cores to support laboratory operations and facilitate research on medical countermeasures. By fostering collaboration among academic, government, and commercial entities, the research aims to improve preparedness and response to potential pandemics and bioterrorism events.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective treatments and preventive measures against serious infectious diseases and bioterrorism threats.
How similar studies have gone: Previous research in biocontainment and drug development has shown success in improving responses to infectious disease outbreaks and bioterrorism threats.
Where this research is happening
-
University of Tennessee Health Sci Ctr
Memphis, United States Active
Researchers
- Principal investigator: Jonsson, Colleen B — University of Tennessee Health Sci Ctr
- Study coordinator: Jonsson, Colleen B
Related research
Other NIH-funded projects on the same topics.
-
Cognitive SuperAging: Exploring why some octogenarians stay sharp in memory
This NIH grant studies why a small group of people aged 80+ keep memory skills as good as much younger people, hoping to understand how to protect memory as we age.
-
National Neighborhood Data Archive helps researchers study aging health in U.S. neighborhoods
A nationwide data resource will help researchers understand how where people live affects health and aging, with a focus on respiratory illnesses in older adults.
-
Understanding how neurons resist and recover from toxic chemicals
Researchers are studying how brain cells fight back against harmful chemicals to help people survive exposure.
-
Fostering Community Connections to Strengthen Youth Resilience and Well-Being
A Hawaii-based effort helps teens and young adults get mental health and preventive care more easily by building local networks and smart referral pathways.
-
Indigenous healthy homes and communities to improve health and resilience
A community-led effort in Indigenous communities in the US Southwest aims to improve housing and health, focusing on safer homes, cleaner indoor environments, and access to culturally competent care.
-
Neural Circuitry Resilience in Psychotic Disorders
Researchers are using ultra-high-field brain scans to understand how brain networks in people with schizophrenia adapt over time, with the goal of finding new ways to improve thinking and daily functioning.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.